Shahbano Shakeel
机构：The University of Texas Southwestern Medical Center
发表论文 6 篇 · 总被引 10 次 · h-index 2
代表论文
- CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer (2025 · Journal of Clinical Investigation · 被引 5)
- Phase 1 pilot study with dose expansion of chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer. (2022 · Journal of Clinical Oncology · 被引 3)
- Abstract OT2-17-01: Phase 1 trial of anthracycline chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer (2023 · Cancer Research · 被引 2)
- Abstract PS5-08-28: Phase I pilot of pegylated liposomal doxorubicin, CD40 agonist antibody CDX-1140, and Flt3 ligand CDX-301 in advanced HER2-negative breast cancer (2026 · Clinical Cancer Research)
- Abstract P3-12-30: Phase I trial of pegylated liposomal doxorubicin chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic HER2 negative breast cancer (2025 · Clinical Cancer Research)
- Abstract PO1-19-08: Phase I trial of pegylated liposomal doxorubicin chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer (2024 · Cancer Research)